Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Remo Poto

Showing results (31-40 of 61) with videos related to

Pageof 7
Sort By:
Frontiers in Immunology|June 13, 2022
Differential Effects of Alarmins on Human and Mouse BasophilsAdriana R Gambardella, Remo Poto, Valentina Tirelli, et al.
Frontiers in Immunology|October 16, 2023
Cytokine dysregulation despite immunoglobulin replacement therapy in common variable immunodeficiency (CVID)Remo Poto, Antonio Pecoraro, Anne Lise Ferrara, et al.
Biomedicines|June 26, 2026
Allergen Immunotherapy and Possible Clinical Remission: Toward a Disease-Modifying Paradigm in Allergic DisordersFabiana Furci, Remo Poto, Corrado Pelaia, et al.
Expert Opinion on Investigational Drugs|September 25, 2019
Tezepelumab: a novel biological therapy for the treatment of severe uncontrolled asthmaGiancarlo Marone, Giuseppe Spadaro, Mariantonia Braile, et al.
Frontiers in Allergy|December 1, 2025
Key role of thymic stromal lymphopoietin as a molecular target for biologic treatment of severe asthmaCorrado Pelaia, James Melhorn, Giovanni Paoletti, et al.
European Journal of Internal Medicine|September 27, 2025
Effectiveness of tezepelumab in severe asthma: A multicenter real-world studyRemo Poto, Gianluca Manganello, Antonio di Salvatore, et al.
European Journal of Internal Medicine|September 7, 2025
T follicular helper cells (T<sub>FH</sub>): From physiological to pathological agingLaura de Lisio, Remo Poto, Laura Andreea Ceparano, et al.
Frontiers in Immunology|October 5, 2020
Is There a Role for Basophils in Cancer?Giancarlo Marone, John T Schroeder, Fabrizio Mattei, et al.
Allergy|August 11, 2022
Biologics and airway remodeling in severe asthmaGilda Varricchi, Sebastian Ferri, Jack Pepys, et al.
Frontiers in Immunology|August 27, 2024
The JAK1/JAK2 inhibitor ruxolitinib inhibits mediator release from human basophils and mast cellsRemo Poto, Leonardo Cristinziano, Gjada Criscuolo, et al.
Pageof 7

Showing results (31-40 of 61) with videos related to

Sort By:
Pageof 7
Frontiers in Immunology|June 13, 2022
Differential Effects of Alarmins on Human and Mouse BasophilsAdriana R Gambardella, Remo Poto, Valentina Tirelli, et al.
Frontiers in Immunology|October 16, 2023
Cytokine dysregulation despite immunoglobulin replacement therapy in common variable immunodeficiency (CVID)Remo Poto, Antonio Pecoraro, Anne Lise Ferrara, et al.
Biomedicines|June 26, 2026
Allergen Immunotherapy and Possible Clinical Remission: Toward a Disease-Modifying Paradigm in Allergic DisordersFabiana Furci, Remo Poto, Corrado Pelaia, et al.
Expert Opinion on Investigational Drugs|September 25, 2019
Tezepelumab: a novel biological therapy for the treatment of severe uncontrolled asthmaGiancarlo Marone, Giuseppe Spadaro, Mariantonia Braile, et al.
Frontiers in Allergy|December 1, 2025
Key role of thymic stromal lymphopoietin as a molecular target for biologic treatment of severe asthmaCorrado Pelaia, James Melhorn, Giovanni Paoletti, et al.
European Journal of Internal Medicine|September 27, 2025
Effectiveness of tezepelumab in severe asthma: A multicenter real-world studyRemo Poto, Gianluca Manganello, Antonio di Salvatore, et al.
European Journal of Internal Medicine|September 7, 2025
T follicular helper cells (T<sub>FH</sub>): From physiological to pathological agingLaura de Lisio, Remo Poto, Laura Andreea Ceparano, et al.
Frontiers in Immunology|October 5, 2020
Is There a Role for Basophils in Cancer?Giancarlo Marone, John T Schroeder, Fabrizio Mattei, et al.
Allergy|August 11, 2022
Biologics and airway remodeling in severe asthmaGilda Varricchi, Sebastian Ferri, Jack Pepys, et al.
Frontiers in Immunology|August 27, 2024
The JAK1/JAK2 inhibitor ruxolitinib inhibits mediator release from human basophils and mast cellsRemo Poto, Leonardo Cristinziano, Gjada Criscuolo, et al.
Pageof 7